Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy
| Image |  |
|---|---|
| Description | scientific article published on 15 April 2009 |
| Author/s |
author: Susan O'Brien Gautam Borthakur Steven M Kornblau Jorge Eduardo Cortes Hagop Kantarjian Jianqin Shan |
| Publication date | April 15, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |